CD79A and B-cell chronic lymphocytic leukemia: We observed significant variations in the IgA levels according to disease evolution (c-CLL vs. p-CLL) and for IgG1 according to IGHV mutational status (M-IGHV vs. U-IGHV) (Supplementary Figure S2).